Hubei Guangji Pharmaceutical Co., Ltd. (SHE:000952)
China flag China · Delayed Price · Currency is CNY
7.46
+0.07 (0.95%)
May 6, 2026, 3:04 PM CST

SHE:000952 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
329.05278.49307.18415.24431.35293.33
Cash & Short-Term Investments
329.05278.49307.18415.24431.35293.33
Cash Growth
-22.09%-9.34%-26.02%-3.74%47.05%-16.26%
Accounts Receivable
249.83256.81223.19297.42294.62197.61
Other Receivables
7.756.486.646.08-0.55
Receivables
257.58263.29229.83303.51299.7203.33
Inventory
213.42257.65322.03298.99221.47164.83
Other Current Assets
58.1745.0561.7866.9352.9747.47
Total Current Assets
858.22844.49920.821,0851,005708.96
Property, Plant & Equipment
1,1431,1721,5771,6371,1991,069
Long-Term Investments
53.7754.137.2835.244.1339.79
Other Intangible Assets
202.37203.82239.62216.91150.62154.72
Long-Term Deferred Tax Assets
25.324.7820.7315.8827.7324.81
Long-Term Deferred Charges
54.819.1210.150.58-
Other Long-Term Assets
6.568.3418.8230.1342.2551.43
Total Assets
2,2942,3132,7943,0302,4702,049
Accounts Payable
166.88182.36121.22143.02178.6121.62
Accrued Expenses
21.7124.3933.6733.5432.2436.94
Short-Term Debt
567.21521.98344.24291.06197.13241.71
Current Portion of Long-Term Debt
529.32565.94132.8161.5158.9199.61
Current Portion of Leases
--1.051.591.20.84
Current Income Taxes Payable
8.98.140.370.221.852.61
Current Unearned Revenue
26.3910.686.47.075.4912.13
Other Current Liabilities
70.7572.83287.77227.8778.6124.82
Total Current Liabilities
1,3911,386927.51865.87654.03540.29
Long-Term Debt
141.98209.3393.75417.29301.5634.45
Long-Term Leases
0.740.991.352.253.191.65
Long-Term Unearned Revenue
11.9512.5713.315.6518.1221.04
Long-Term Deferred Tax Liabilities
0.330.360.50.690.920.33
Other Long-Term Liabilities
154.5876.11380.96335.320.340.33
Total Liabilities
1,7011,6861,7171,637978.17598.09
Common Stock
346.63346.75349.86353.86353.97344
Additional Paid-In Capital
361.59361.06377.12391.79391.09353.92
Retained Earnings
-77.87-46.23358.27653.56793.8764.58
Treasury Stock
-9.47-9.89-21.23-35.75-36.19-
Comprehensive Income & Other
2.72.080.93-0.01-0.02-0.03
Total Common Equity
623.58653.771,0651,3631,5031,462
Minority Interest
-29.89-26.9211.2629-10.83-11.67
Shareholders' Equity
593.68626.851,0761,3921,4921,451
Total Liabilities & Equity
2,2942,3132,7943,0302,4702,049
Total Debt
1,2391,298873.19873.69662378.26
Net Cash (Debt)
-910.2-1,020-566.01-458.45-230.65-84.93
Net Cash Per Share
-2.62-2.89-1.61-1.30-0.65-0.25
Filing Date Shares Outstanding
346.59346.65349.86353.86353.97344
Total Common Shares Outstanding
346.59346.65349.86353.86353.97344
Working Capital
-532.93-541.83-6.69218.8351.46168.67
Book Value Per Share
1.801.893.043.854.254.25
Tangible Book Value
421.2449.95825.321,1471,3521,308
Tangible Book Value Per Share
1.221.302.363.243.823.80
Buildings
--1,1631,196899.49839.29
Machinery
--1,4561,370942.21840.98
Construction In Progress
--33.160.96258.14204.47
Source: S&P Global Market Intelligence. Standard template. Financial Sources.